Ascendis Pharma A/S Adjustments For Amortisation Expense
Ascendis Pharma A/S (ASND) reported Adjustments For Amortisation Expense of EUR 490.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForAmortisationExpense · last filed 2026-02-11
- Ascendis Pharma A/S adjustments for amortisation expense for the quarter ending 2025-12-31 was 129.00K EUR, a 8.40% increase year-over-year.
- Ascendis Pharma A/S adjustments for amortisation expense for the quarter ending 2025-09-30 was 123.00K EUR, a 6.96% increase year-over-year.
- Ascendis Pharma A/S adjustments for amortisation expense for the quarter ending 2025-06-30 was 119.00K EUR, a 3.48% increase year-over-year.
- Ascendis Pharma A/S adjustments for amortisation expense for the quarter ending 2025-03-31 was 119.00K EUR, a 0.85% increase year-over-year.
| Period end | Adjustments For Amortisation Expense 3 month | Adjustments For Amortisation Expense 6 month | Adjustments For Amortisation Expense 9 month | Adjustments For Amortisation Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | 129.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 252.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | 371.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 490.00K EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 123.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 242.00K EUR derived: sum of 2 quarters · filed 2025-11-12 | 361.00K EUR 6-K · filed 2025-11-12 | 480.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 119.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 238.00K EUR 6-K · filed 2025-08-07 | 357.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 472.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 119.00K EUR 6-K · filed 2025-05-01 | 238.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | 353.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 468.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 119.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 234.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | 349.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 467.00K EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 115.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 230.00K EUR derived: sum of 2 quarters · filed 2025-11-12 | 348.00K EUR 6-K · filed 2025-11-12 | 498.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 115.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 233.00K EUR 6-K · filed 2025-08-07 | 383.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 494.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 118.00K EUR 6-K · filed 2025-05-01 | 268.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | 379.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 490.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 150.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 261.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | 372.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 483.00K EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 111.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | 222.00K EUR derived: sum of 2 quarters · filed 2024-11-14 | 333.00K EUR 6-K · filed 2024-11-14 | 444.00K EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 111.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | 222.00K EUR 6-K · filed 2024-09-03 | 333.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | 444.00K EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 111.00K EUR 6-K · filed 2024-05-02 | 222.00K EUR derived: sum of 2 quarters · filed 2025-02-12 | 333.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | 444.00K EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 111.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 222.00K EUR derived: sum of 2 quarters · filed 2025-02-12 | 333.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | 444.00K EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 111.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 222.00K EUR derived: sum of 2 quarters · filed 2023-11-07 | 333.00K EUR 6-K · filed 2023-11-07 | 445.00K EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 111.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 222.00K EUR 6-K · filed 2023-09-05 | 334.00K EUR derived: sum of 3 quarters · filed 2024-02-07 | 445.00K EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 111.00K EUR 6-K · filed 2023-04-27 | 223.00K EUR derived: sum of 2 quarters · filed 2024-02-07 | 334.00K EUR derived: sum of 3 quarters · filed 2024-02-07 | 445.00K EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 112.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 223.00K EUR derived: sum of 2 quarters · filed 2024-02-07 | 334.00K EUR derived: sum of 3 quarters · filed 2024-02-07 | 445.00K EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 111.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | 222.00K EUR derived: sum of 2 quarters · filed 2022-11-02 | 333.00K EUR 6-K · filed 2022-11-02 | |
| 2021-06-30 | 111.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | 222.00K EUR 6-K · filed 2022-08-10 | ||
| 2021-03-31 | 111.00K EUR 6-K · filed 2022-05-11 |